サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1759000

バイオマニュファクチャリングウイルスの検出と定量の世界市場

Biomanufacturing Viral Detection and Quantifications

出版日
ページ情報
英文 484 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
バイオマニュファクチャリングウイルスの検出と定量の世界市場
出版日: 2025年06月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 484 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオマニュファクチャリングウイルスの検出と定量の世界市場は2030年までに7億9,320万米ドルに達する見込み

2024年に5億4,780万米ドルと推定されるバイオマニュファクチャリングウイルスの検出と定量の世界市場は、2030年には7億9,320万米ドルに達し、分析期間2024-2030年のCAGRは6.4%で成長すると予測されます。本レポートで分析したセグメントの1つである消耗品提供は、CAGR 5.3%を記録し、分析期間終了時には4億6,410万米ドルに達すると予測されます。機器提供セグメントの成長率は、分析期間中CAGR 8.3%と推定されます。

米国市場は1億4,920万米ドルと推定、中国はCAGR 9.8％で成長予測

米国のバイオマニュファクチャリングウイルスの検出と定量市場は、2024年に1億4,920万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.8%で推移し、2030年には1億6,130万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.1%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界のバイオマニュファクチャリングウイルスの検出と定量市場- 主要動向と促進要因のまとめ

今日のバイオマニュファクチャリングにおいてウイルス検出と定量化が重要な理由とは？

バイオマニュファクチャリングの分野では、ウイルスの検出と定量が不可欠なプロセスとなっており、生物学的由来の製品の安全性、品質、有効性を保証しています。モノクローナル抗体、遺伝子治療薬、ワクチン、組換えタンパク質などの生物製剤は、多くの場合、開発、製造、包装の段階でウイルス汚染の影響を受けやすい生きた細胞系を用いて製造されます。原材料、宿主細胞、生産環境のいずれからであれ、微量の不定性ウイルスでさえ、製品バッチ全体を危険にさらし、規制の不適合につながり、患者に深刻な健康リスクをもたらす可能性があります。したがって、検出（ウイルスの存在を特定すること）と定量（ウイルス量または力価を測定すること）の両方を含む包括的なウイルス安全性戦略は、バイオ製造ワークフローにとって極めて重要です。これらのプロセスは、最終的なバイオ医薬品が既知のウイルス汚染物質と新興のウイルス汚染物質の両方から排除されていることを保証するのに役立ちます。FDA、EMA、WHOなどの規制機関は、開発ライフサイクルを通じて厳格なウイルス安全性試験とバリデーションを義務付けており、この分野は技術的に必要なだけでなく、法的にも必須となっています。さらに、複雑な生物製剤や個別化治療、特に細胞治療や遺伝子治療の台頭により、ウイルス検出システムの感度と精度もそれに応じて進化しなければならないです。このような環境において、信頼性の高いウイルスモニタリングは、バイオ医薬品分野における製造保証、製品の一貫性、公衆衛生保護の要となっています。

検出技術の革新は、バイオ製造におけるウイルスの安全性をどのように向上させているか？

技術の進歩により、バイオマニュファクチャリングにおけるウイルス検出と定量化の精度、スピード、感度が大幅に向上しています。in vivoの動物実験やin vitroの細胞培養アッセイといった伝統的な方法は、依然として重要ではあるが、最新の分子技術によって補完されたり、取って代わられたりすることが増えています。リアルタイム定量ポリメラーゼ連鎖反応（qPCR）やデジタルPCRは、特定のウイルスゲノムを高精度で迅速に検出・定量できることから、ゴールドスタンダードとなっています。さらに、次世代シーケンシング（NGS）技術は、既知および新規のウイルス汚染物質の偏りのない同定を可能にすることで、ウイルス検出に革命をもたらし、初期段階および後期段階の製造における安全性を強化しています。これらの技術は、遺伝子レベルでの包括的なウイルス監視を可能にするハイスループット、ディープシーケンス機能を提供します。バイオインフォマティクスの進歩により、膨大なデータセットを迅速に解析し、非常に低濃度であってもウイルスのシグネチャーを特定できるようになりました。その他の技術革新としては、表面プラズモン共鳴（SPR）を用いたバイオセンサー、モノクローナル抗体の特異性を高めたイムノアッセイ、ウイルスタンパク質をプロファイリングする質量分析技術などがあります。検査ワークフローの自動化とデジタル化により、手作業によるミスが減少し、バッチ間の一貫性が確保されています。人工知能もまた、汚染リスクを予測し、検出プロトコルを最適化するために活用されています。これらの最先端技術は、検出限界を向上させ、偽陽性／陰性を減らすだけでなく、バイオ製造中のリアルタイム・インライン・モニタリングを容易にし、より迅速な是正措置を可能にしています。その結果、これらの技術革新はバイオ製造業界全体のウイルス安全性の基準を引き上げ、重要な治療薬製造をサポートする強固なシステムを構築しています。

バイオマニュファクチャリングにおけるウイルス安全性の推進をリードしている分野と地域は？

バイオマニュファクチャリングにおける効果的なウイルス検出と定量化の需要は、製薬業界とバイオテクノロジー業界を筆頭に、複数のセクターによって推進されています。生物製剤、特にモノクローナル抗体、組換えタンパク質、細胞・遺伝子治療、ワクチンを製造する企業は、厳格なウイルス監視プロトコルの必要性が最も高いです。AAV（アデノ随伴ウイルス）やレンチウイルスのような遺伝子治療用ベクターは特にそうで、安全性、投与量の一貫性、治療効果を確保するために正確な定量が要求されます。CDMO（開発・製造受託機関）も重要な役割を担っており、小規模なバイオテクノロジー企業や臨床段階の開発企業にとって重要なサービスとしてウイルス安全性試験を提供しています。製薬業界に加え、診断薬業界も、特にウイルス試薬を含む製品や細胞培養由来の製品について、ウイルスの定量化にますます力を入れています。地理的には、北米が市場をリードしており、これは高度なバイオ製造インフラ、強力な規制監督、生物学的製剤開発への多額の投資によって支えられています。米国はFDAと多くの大手バイオテクノロジー企業の本拠地であり、ウイルスの安全性に関する世界標準を定めています。欧州は、EMAの厳格な品質規制とドイツ、英国、スイスなどの国々における成熟した生物製剤エコシステムに牽引され、その後に続いています。アジア太平洋、特に中国、韓国、インド、日本は、バイオ製造能力の急速な成長を経験しており、世界の輸出基準を満たすために品質管理に多額の投資を行っています。これらの地域はまた、国内の生物学的製剤の生産を強化しており、ウイルス安全性保証の需要をさらに煽っています。世界的には、パンデミック対策イニシアチブの拡大と新興市場における生物製剤の台頭が、ウイルス検出・定量化需要の地理的範囲を広げています。

世界のバイオマニュファクチャリングウイルスの検出と定量市場の成長を促進しているのは？

世界のバイオマニュファクチャリングウイルスの検出と定量市場の成長は、複雑な生物製剤の生産量の増加、規制当局の監視の強化、ウイルスアウトブレイクの発生率の増加、検出技術の継続的な進歩など、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、生物学的製剤や先進治療、特に遺伝子治療や細胞治療のパイプラインが拡大していることです。これらの治療にはウイルスベクターが使用されたり、ウイルスが発生しやすい環境で生産されたりすることが多いため、高感度の検出と正確な定量が絶対的に重要になります。規制機関はウイルス安全性要件を厳しくしており、メーカーは最新で最も堅牢な検査手法を採用するよう求められています。知名度の高いリコールや汚染事件もウイルスリスクに対する認識を高め、予防的品質管理への投資拡大につながっています。もう一つの大きな成長要因は、生物学的サプライチェーンの脆弱性を露呈したCOVID-19危機以降、パンデミックへの備えとバイオサーベイランスに世界的に注目が集まっていることです。このため、最終製品だけでなく、原料やプロセス中間体についても、高速でスケーラブルなウイルス検出システムへの需要が加速しています。特にデジタルPCR、NGS、AIベースの分析における技術革新は、検査コストを下げ、アクセシビリティを向上させ、連続的なバイオプロセス環境へのウイルスモニタリングの統合を容易にしています。さらに、バイオ製造の世界化とCDMOの台頭により、ウイルス検出の要件は世界中の新しい市場と施設に拡大しています。これらの動向は、プロトコルの標準化と普遍的な検出フレームワークの開発を目的とした、診断薬企業、規制機関、学術機関の戦略的パートナーシップにも支えられています。これらの推進力を総合すると、ウイルスの検出と定量は、今後も生物製剤の安全でスケーラブルかつコンプライアンスに適合した製造に不可欠なものです。

セグメント

提供（消耗品、機器、サービス）、技術（PCR技術、ELISA技術、フローサイトメトリー技術、プラークアッセイ技術、その他技術）、用途（血液・血液製品製造用途、ワクチン・治療薬製造用途、細胞・遺伝子治療製品製造用途、幹細胞製品製造用途、組織・組織製品製造用途）、最終用途（ライフサイエンス企業最終用途、検査機関最終用途、CRO・CDMO最終用途）

調査対象企業の例（注目の43社）

  • Abingdon Health
  • Agilent Technologies, Inc.
  • Ayoxxa Biosystems
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurogentec
  • FUJIFILM Diosynth Biotechnologies
  • GenScript Biotech Corporation
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corp.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36384

Global Biomanufacturing Viral Detection and Quantifications Market to Reach US$793.2 Million by 2030

The global market for Biomanufacturing Viral Detection and Quantifications estimated at US$547.8 Million in the year 2024, is expected to reach US$793.2 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Consumables Offering, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$464.1 Million by the end of the analysis period. Growth in the Instruments Offering segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$149.2 Million While China is Forecast to Grow at 9.8% CAGR

The Biomanufacturing Viral Detection and Quantifications market in the U.S. is estimated at US$149.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Biomanufacturing Viral Detection and Quantifications Market - Key Trends & Drivers Summarized

Why Is Viral Detection and Quantification Crucial in Biomanufacturing Today?

In the field of biomanufacturing, viral detection and quantification have become indispensable processes, ensuring the safety, quality, and efficacy of biologically-derived products. Biologics, such as monoclonal antibodies, gene therapies, vaccines, and recombinant proteins, are often produced using living cell systems that can be vulnerable to viral contamination during development, production, or packaging stages. Even trace amounts of adventitious viruses-whether from raw materials, host cells, or the production environment-can compromise entire product batches, lead to regulatory non-compliance, and pose serious health risks to patients. Therefore, comprehensive viral safety strategies involving both detection (identifying the presence of viruses) and quantification (measuring viral load or titer) are critical to biomanufacturing workflows. These processes help ensure that final biopharmaceutical products are free from both known and emerging viral contaminants. Regulatory agencies such as the FDA, EMA, and WHO mandate rigorous viral safety testing and validation throughout the development lifecycle, making this area not just a technical necessity but a legal imperative. Moreover, with the rise of complex biologics and personalized therapies-especially cell and gene therapies-the sensitivity and accuracy of viral detection systems must evolve accordingly. In this environment, reliable viral monitoring has become a cornerstone of manufacturing assurance, product consistency, and public health protection in the biopharma sector.

How Are Innovations in Detection Technologies Improving Viral Safety in Biomanufacturing?

Technological advancements are significantly enhancing the accuracy, speed, and sensitivity of viral detection and quantification in biomanufacturing. Traditional methods such as in vivo animal testing and in vitro cell culture assays, while still important, are increasingly being complemented or replaced by modern molecular techniques. Real-time quantitative polymerase chain reaction (qPCR) and digital PCR have become gold standards for their ability to detect and quantify specific viral genomes with high precision and rapid turnaround times. Additionally, next-generation sequencing (NGS) technologies are revolutionizing viral detection by enabling unbiased identification of both known and novel viral contaminants, thereby strengthening safety in early and late-stage manufacturing. These techniques offer high-throughput, deep-sequencing capabilities that allow for comprehensive viral surveillance at the genetic level. Advances in bioinformatics are further empowering researchers to analyze massive datasets quickly, identifying viral signatures even at very low concentrations. Other innovations include biosensors using surface plasmon resonance (SPR), immunoassays with enhanced monoclonal antibody specificity, and mass spectrometry techniques that profile viral proteins. Automation and digitalization of testing workflows are reducing manual errors and ensuring consistency across batches. Artificial intelligence is also being leveraged to predict contamination risks and optimize detection protocols. These cutting-edge technologies not only improve detection limits and reduce false positives/negatives but also facilitate real-time, in-line monitoring during biomanufacturing, enabling faster corrective actions. As a result, these innovations are raising the standard of viral safety across the biomanufacturing industry and creating robust systems to support high-stakes therapeutic production.

Which Sectors and Geographies Are Leading the Push for Viral Safety in Biomanufacturing?

The demand for effective viral detection and quantification in biomanufacturing is being driven by multiple sectors, with the pharmaceutical and biotechnology industries at the forefront. Companies producing biologics-especially monoclonal antibodies, recombinant proteins, cell and gene therapies, and vaccines-have the highest need for stringent viral monitoring protocols. This is particularly true for gene therapy vectors like AAVs (adeno-associated viruses) and lentiviruses, which require exact quantification to ensure safety, dose consistency, and therapeutic efficacy. CDMOs (contract development and manufacturing organizations) also play a key role, offering viral safety testing as a critical service for smaller biotech firms and clinical-stage developers. In addition to pharma, the diagnostics industry is increasingly focused on viral quantification, especially for products involving viral reagents or derived from cell cultures. Geographically, North America leads the market, bolstered by its advanced biomanufacturing infrastructure, strong regulatory oversight, and heavy investments in biologic development. The U.S., home to the FDA and many leading biotech firms, sets global standards for viral safety. Europe follows closely, driven by the EMA’s stringent quality regulations and a mature biologics ecosystem in countries like Germany, the UK, and Switzerland. Asia-Pacific, particularly China, South Korea, India, and Japan, is experiencing rapid growth in biomanufacturing capabilities and is investing heavily in quality control to meet global export standards. These regions are also ramping up domestic biologic production, further fueling the demand for viral safety assurance. Globally, the expansion of pandemic preparedness initiatives and the rise of biologics across emerging markets are broadening the geographic scope of demand for viral detection and quantification.

What Is Fueling the Growth in the Global Biomanufacturing Viral Detection and Quantifications Market?

The growth in the global biomanufacturing viral detection and quantifications market is driven by several key factors: the increasing production of complex biologics, rising regulatory scrutiny, growing incidence of viral outbreaks, and ongoing advancements in detection technologies. One of the primary growth drivers is the expanding pipeline of biologic drugs and advanced therapies-particularly gene and cell therapies-which require meticulous viral safety monitoring at every stage. These treatments often involve viral vectors or are produced in viral-prone environments, making sensitive detection and precise quantification absolutely critical. Regulatory agencies are tightening viral safety requirements, pushing manufacturers to adopt the latest, most robust testing methodologies. High-profile recalls and contamination incidents have also increased awareness of viral risks, leading to greater investment in preventive quality control. Another major growth factor is the global focus on pandemic preparedness and biosurveillance following the COVID-19 crisis, which exposed vulnerabilities in biological supply chains. This has accelerated demand for fast, scalable viral detection systems not just for finished products, but also for raw materials and process intermediates. Technological innovation-particularly in digital PCR, NGS, and AI-based analytics-is lowering testing costs, improving accessibility, and making it easier to integrate viral monitoring into continuous bioprocessing environments. Furthermore, the globalization of biomanufacturing and the rise of CDMOs are extending viral detection requirements to new markets and facilities worldwide. These trends are also supported by strategic partnerships between diagnostics companies, regulatory bodies, and academic institutions aimed at standardizing protocols and developing universal detection frameworks. Altogether, these drivers are ensuring that viral detection and quantification remain indispensable to the safe, scalable, and compliant production of biologics in the years ahead.

SCOPE OF STUDY:

The report analyzes the Biomanufacturing Viral Detection and Quantifications market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Consumables Offering, Instruments Offering, Services Offering); Technology (PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology, Other Technologies); Application (Blood & Blood Products Manufacturing Application, Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application); End-Use (Life Science Companies End-Use, Testing Laboratories End-Use, CROs & CDMOs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abingdon Health
  • Agilent Technologies, Inc.
  • Ayoxxa Biosystems
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurogentec
  • FUJIFILM Diosynth Biotechnologies
  • GenScript Biotech Corporation
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corp.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Biomanufacturing Viral Detection and Quantifications - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Stringent Regulatory Requirements Throw the Spotlight on Viral Detection and Quantification in Biomanufacturing
    • Rising Adoption of Cell and Gene Therapies Spurs Demand for Precise Viral Load Monitoring Techniques
    • Here's How Advancements in qPCR, ddPCR, and NGS Are Transforming Viral Safety Testing in Bioproduction
    • Biologics and Vaccine Pipeline Expansion Strengthens the Business Case for In-Line and At-Line Viral Monitoring
    • Growing Emphasis on Contamination Control Drives Investment in Rapid and High-Sensitivity Detection Tools
    • Automation of Viral Assays Enhances Throughput and Reduces Human Error in Bioprocessing Environments
    • Increased Outsourcing to CDMOs Fuels Demand for Standardized and Scalable Viral Quantification Solutions
    • Here's the Story: How Digital Technologies Are Powering Real-Time Process Analytics for Viral Safety
    • Integration of Viral Clearance Validation into QbD Strategies Expands the Role of Detection Systems in Process Design
    • Emergence of Continuous Biomanufacturing Models Creates Opportunities for Inline Viral Monitoring Systems
    • Rising Complexity of Viral Vectors in Gene Therapy Manufacturing Drives Need for Advanced Quantification Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biomanufacturing Viral Detection and Quantifications Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biomanufacturing Viral Detection and Quantifications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vaccines & Therapeutics Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vaccines & Therapeutics Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vaccines & Therapeutics Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cellular & Gene Therapy Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cellular & Gene Therapy Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cellular & Gene Therapy Products Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Stem Cell Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Stem Cell Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Stem Cell Products Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Tissue & Tissue Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Tissue & Tissue Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Tissue & Tissue Products Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Blood & Blood Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Blood & Blood Products Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Blood & Blood Products Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Life Science Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Life Science Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Life Science Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Testing Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Testing Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Testing Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for CROs & CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for CROs & CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for CROs & CDMOs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for ELISA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for ELISA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for ELISA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Plaque Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Plaque Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Plaque Assay Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • JAPAN
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CHINA
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: China 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • EUROPE
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • FRANCE
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 116: France Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: France 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • GERMANY
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 152: UK Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Spain 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Russia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Australia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • INDIA
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 227: India Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: India 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: South Korea 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Argentina 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Brazil 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Mexico 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Iran 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Israel 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: UAE 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AFRICA
    • Biomanufacturing Viral Detection and Quantifications Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Biomanufacturing Viral Detection and Quantifications by Offering - Consumables Offering, Instruments Offering and Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: Africa 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Services Offering for the Years 2014, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Biomanufacturing Viral Detection and Quantifications by Application - Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Application - Percentage Breakdown of Value Sales for Vaccines & Therapeutics Manufacturing Application, Cellular & Gene Therapy Products Manufacturing Application, Stem Cell Products Manufacturing Application, Tissue & Tissue Products Manufacturing Application and Blood & Blood Products Manufacturing Application for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Biomanufacturing Viral Detection and Quantifications by End-Use - Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by End-Use - Percentage Breakdown of Value Sales for Life Science Companies End-Use, Testing Laboratories End-Use and CROs & CDMOs End-Use for the Years 2014, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Biomanufacturing Viral Detection and Quantifications by Technology - PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Biomanufacturing Viral Detection and Quantifications by Technology - Percentage Breakdown of Value Sales for PCR Technology, ELISA Technology, Flow Cytometry Technology, Plaque Assay Technology and Other Technologies for the Years 2014, 2025 & 2030

IV. COMPETITION